Search Tag: HPV
2021 05 Nov
New research, funded by Cancer Research UK and published in The Lancet, found 87% lower cervical cancer rates in English women who were offered the Cervarix human papillomavirus (HPV) vaccine vaccinated at ages 12 and 13 than unvaccinated women of similar age. This study provides the first direct evidence of Cervarix‘s effectiveness in lowering cervical...Read more
2015 16 Dec
-- The CE-marked Aptima® Mycoplasma genitalium Assay on the Panther® System Identifies a Prevalent, Often Misdiagnosed Sexually Transmitted Infection -- Hologic, Inc. has announced the European launch of the CE-marked Aptima Mycoplasma genitalium assay, adding to the growing menu of molecular tests available on the fully automated Panther system....Read more
2015 10 Dec
-- Aptima® HBV Quant Assay Joins Tests for HIV-1 and HCV on the Fully Automated Panther Instrument -- Hologic, Inc. has earned CE-IVD certification for its Aptima HBV Quant assay on the fully automated Panther® instrument, the Company has announced. This assay expands the European virology menu available on the Panther system, which previously...Read more
2015 12 Jan
The Society of Gynecologic Oncology (SGO) and the American Society for Colposcopy and Cervical Pathology (ASCCP) have issued a new interim guidance for cervical cancer screening that recommends the use of a human papillomavirus (HPV) test alone as the primary screen to find cervical cancer or its precursors. At present, such screening is done with either...Read more